Saturday Morning Class #2: How is Lp(a) measured and why does it matter?
Time to try to clear up the confusion: about 15 yr after Lp(a) was discovered in 1963 by Kare Berg, Prof John Albers at UWash created an assay to measure Lp(a).
1/19
He based this on the whole “mass” of Lp(a) and all its components (apoB, apo(a), cholesterol and cholesteryl esters, phospholipids, triglyceride and carbohydrate on Lp(a). (ncbi.nlm.nih.gov/pubmed/405443)
2/19
What is mass: it is a property of a physical object that quantifies the amount of matter it contains. Unlike weight, the mass of something stays the same regardless of location. Fun fact: in Einstein’s E=MC2, M is the mass of an object. 3/19
Amazing that 5 characters could explain how most things in the Universe work.
How is Lp(a) measured: you need 3 things: 1- an antibody to detect apo(a) and 2- reference samples of absolute known values based on another method, 3- a detecting system. 4/19
For example, an Lp(a) value of 10 mg/dL will give 10 arbitrary units (color, light, radioactivity, etc depending on method), a value of 100 mg/dL will give 100 units. The patient’s sample is then taken, if it has 23 units, the value give is 23 mg/dL, etc. 5/19
This method, and John, became a shooting star (“Johnny made a record, went up to number 1”: , great song…). 6/19
Problem #1: patients have different proportions of each component and the antibody in the assay only binds one component (apo(a)), but the standards are based on 7 components, so error of measurement could be significant 7/19
Problem #2: the mass assay, in mg/dL, gets entrenched clinically so physicians understand it and in labs measure it. Inertia sets in not to innovate. Unlike Johnny’s untimely demise in the Bad Company song, the Lp(a) mass assay had many more #1s. 8/19
Problem #3: unlike most other proteins, Lp(a) has multiple “kringles”, they look like a string of identical pearls. (Fun fact; kringle comes from a Danish pastry folded over twice. Pic from on recent trip to Solvang CA). 9/19
Most antibodies recognize all these kringles, thus bind more than once which is a problem. They can have an artifact due to this, higher signal or lower signal, relative to the reference standards, adding a second layer of error 10/19
So, 15 years after this comes along Dr Santica Marcovina, also at UWash, who created an apo(a) particle concentration method that only measures apo(a) component and only binds once per particle, and validates the standards to this, so no over or under-reading 11/19
This measures the number of circulating apo(a) particles only, and not the other components, thus true reflector of Lp(a) ncbi.nlm.nih.gov/pubmed/7533064. (Fun fact: there is a lovely story behind this, where the understudy overtakes the Professor, but it ends well for both). 12/19
This is reported as nanomoles apo(a) per liter of plasma (nmol/L or nM). This has the least bias in accurately reading values. There are other contributors to this story but not enough space to describe, hope no one is offended 13/19
Problem #4: this assay is only available at UWash, but is used to certify commercial systems.
A third measure of “Lp(a)-cholesterol” is reported in mg/dL, only estimating the cholesterol content of Lp(a), but this particular methods is highly inaccurate. 14/19
1-For your results, check if in mg/dL, nmol/L or Lp(a) cholesterol. The normal levels are <30 mg/dL, <75 nmo/L and <10 mg/dL, respectively. I had a patient that had all 3 measured and neither he or his referring physician could make sense of it 16/19
2-Because the mg/dL and nmol/L measure different things, there is no “conversion factor” that is accurate. On average its about 2.5 for mg/dL to nmol/L (based on numbers above), but could range from 1.5-4 or even more, one could use a range of 1. ncbi.nlm.nih.gov/pubmed/30100157 17/19
3-There is natural variability in Lp(a), up to 25%, just like with other lipids. For example, TGs are even more variable. This variability is around a preset genetic threshold, so a patient with level of 100 can never go to 20 without Rx 18/19 ncbi.nlm.nih.gov/pubmed/29174389
4- The field is moving away from mg/dL assays and these should disappear in about 5-10 yrs, as rec by an NHLBI Working group.
5-In meantime, we just need to be aware of these issues so that we can properly interpret the data 19/19
Quiz:
Q1- 5- points
Choose the correct answer. The best method to measure Lp(a) to minimize error and bias of multiple identical kringles is:
Q2- 5- points
Choose the correct answer. One can convert mg/dL to nmol/L by:
Bonus questions: 1 point.
What is best sports team in the universe, choose the correct answer:
Hint: its one of these 🏈⚾️🏀🏒- it’s not the Dallas Cowboys
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/19 Saturday Morning Class #19: Lp(a) and receptors
First principles: What is a receptor? One can think of it as a toll gate, you need a code to get into the cell, and the code is done by “facial" recognition software. If the toll does not recognize you, you stay out
2/19 Why do we need receptors? For complex systems like mammals (as opposed to bacteria where most things they need can be done by one cell) eukaryotic cells have needs that have to be supplied by other cells- they need to let in the Amazon trucks with the goods.
3/19 LDL particles made in liver are a good example taken up by LDL receptors by rest of the body. Receptors in the immune system have other functions- they recognize things that are not “self” and remove them to prevent damage, i.e. SARS-Cov-2, bacteria....
There are 2 kinds of apoB: apoB48 which is made by small intestine and apoB-100 made by the liver. ApoB48 and apoB100 come from the same gene, except one is 48% the size of the other, thus the name.
2/19 ApoB48 carries the lipid (fat in form of triglycerides) that one eats to the circulation and it goes to muscle for energy or liver for re-processing. The enzyme lipoprotein lipase (LPL) breaks down the TG into free fatty acids that go to the Krebs cycle for ATP energy
3/19 If one is missing both copies of LPL, one develops milky plasma- chylomicrons that cant be cleared. This causes acute pancreatitis. @IonisPharma has been working on a therapy to treat this by inhibiting ApoCIII which mediates LPL activity and chylomicron clearance
In trying to understand the purely carnivorous diet of the Inuit/Eskimo and Lp(a), I have moved on from Vil S onto a new book: remarkably, the reputable investigators claim Inuit in the wild in 1908 could eat up to 14 pounds!! of seal meat in 24 hr- there goes your diet.....
A few interesting tidbits: 1- Their usual daily intake of protein was >280 grams and fat >135 grams, and carb ~50 grams, half from meat glycogen.
2- Remarkably, despite such high protein intake, they did not seem to have gout, like Europeans. 3- they could work extremely hard and long hours despite few carbs
1/4 Costs of PCSK9 antibodies (initially $14k/yr, now ~$5-6/yr) will come up, so here is a brief summary of this.
1- antibodies are very expensive to make as they are large proteins and have to be made in a biological system rather than chemical synthesis @stsimikas@OxPL_apoB
2/4 2- I dont know what they break even point is, but I suspect you cant make them for <$2-3K/yr, so price will not likely come down more as there will be little profit. 3- at 150 mg every 2 weeks, this is 3,900 mg/yr per patient, so cost is ~$1.50 per mg
3/4 4- for context, in our research lab, 0.1 mg of most research antibodies, that don't need human testing, is ~$300, or ~$3000/mg, i.e about 1500 times more expensive that Repatha and Praluent. If we had to buy 3,900 mg per year, it would cost us over $100,000K
Apologies for delay. We had a tragedy this week- our 2 kids' dear cats Captain Jack and Leonardo, who have graced these pages, were taken by a bobcat and her 3 kittens. Good bye dear friends, we will miss you and never forget you
2/20 First some definitions- what is a PCSK9 protein (Proprotein convertase subtilisin/kexin type 9 (PCSK9). As the name implies, it cleaves other proteins to convert them to an active form. The one of interest to lipid metabolism is type 9.
3/20 It is secreted by the liver, and binds to lipoproteins (LDL, HDL and Lp(a)) in plasma. It then comes back to the liver on LDL/Lp(a) that bind to the LDL receptor. The LDLR/PCSK9 gets internalized and the LDLR is destroyed, resulting in less LDLR in liver cell surface
1/4 Not something I want to dwell on but I had a disclaimer in the tweet that said it depends on how meat is processed. For the study I was referring to, they did measure carbs in meat and there was daily ingestion of liver which will have lots of glycogen, as well as cholesterol
2/4 If the animals are slaughtered in the fasting state, then most glycogen will be depleted or used up to make lactic acid in rigor mortis (ATP depletetion) assuming they dont process it quickly. In modern day, I suspect glycogen (carb) content of muscle (i.e steak) is only 1-2%
3/4 For my own practice, I highly discourage "animal product" keto diets in my patients, simply because they already either have CVD or high risk for it, or genetic disorders that raise their LDL-C, and eating saturated fat and cholesterol is the worst thing they can do